Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T21:00:46.625Z.
Calculation as of: 2026-10-06T21:00:46.625Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c84a17f2c5c981e3cafbb97a54cdccede593a8f239875ee545639e7176ba2e68
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-05-12.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Atara Biotherapeutics, Inc.
Market Cap
$87.85M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$87.27M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$90.20M
EV/EBITDA Ratio
15.00x
TTM Avg
15.77x
3Y Avg
20.95x
5Y Avg
32.73x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | $87.85M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 4.67x | 4.46x | 3.36x | 3.41x |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $87.27M | N/A | N/A | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $89.44M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $89.78M | N/A | N/A | N/A | N/A |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $85.86M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $90.20M | 15.00x | 15.77x | 20.95x | 32.73x |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | N/A | N/A | N/A | N/A |
| Rallybio Corporation (RLYB)vs › | $90.64M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-05-12 | 4.45x |
| 2026-05-11 | 4.11x |
| 2026-05-08 | 3.96x |
| 2026-05-07 | 4.49x |
| 2026-05-06 | 2.89x |
| 2026-05-05 | 2.76x |
| 2026-05-04 | 2.80x |
| 2026-05-01 | 2.81x |
| 2026-04-30 | 2.76x |
| 2026-04-29 | 2.71x |
| 2026-04-28 | 2.75x |
| 2026-04-27 | 2.84x |
| 2026-04-24 | 2.84x |
| 2026-04-23 | 2.81x |
| 2026-04-22 | 2.90x |
| 2026-04-21 | 2.84x |
| 2026-04-20 | 2.84x |
| 2026-04-17 | 2.93x |
| 2026-04-16 | 2.92x |
| 2026-04-15 | 2.92x |
| 2026-04-14 | 2.89x |
| 2026-04-13 | 2.80x |
| 2026-04-10 | 2.72x |
| 2026-04-09 | 2.78x |
| 2026-04-08 | 2.84x |
| 2026-04-07 | 2.74x |
| 2026-04-06 | 2.80x |
| 2026-04-02 | 2.84x |
| 2026-04-01 | 2.90x |
| 2026-03-31 | 2.75x |
| 2026-03-30 | 2.61x |
| 2026-03-27 | 2.70x |
| 2026-03-26 | 2.74x |
| 2026-03-25 | 2.83x |
| 2026-03-24 | 2.84x |
| 2026-03-23 | 2.79x |
| 2026-03-20 | 2.81x |
| 2026-03-19 | 2.88x |
| 2026-03-18 | 2.84x |
| 2026-03-17 | 2.92x |
| 2026-03-16 | 4.51x |
| 2026-03-13 | 4.80x |
| 2026-03-12 | 4.98x |
| 2026-03-11 | 4.67x |
| 2026-03-10 | 4.70x |
| 2026-03-09 | 4.88x |
| 2026-03-06 | 4.18x |
| 2026-03-05 | 4.11x |
| 2026-03-04 | 4.29x |
| 2026-03-03 | 4.30x |
| 2026-03-02 | 4.06x |
| 2026-02-27 | 4.30x |
| 2026-02-26 | 4.23x |
| 2026-02-25 | 4.13x |
| 2026-02-24 | 3.74x |
| 2026-02-23 | 3.74x |
| 2026-02-20 | 3.73x |
| 2026-02-19 | 3.76x |
| 2026-02-18 | 3.84x |
| 2026-02-17 | 3.87x |
| 2026-02-13 | 3.85x |
| 2026-02-12 | 3.85x |
| 2026-02-11 | 3.92x |
| 2026-02-10 | 4.03x |
| 2026-02-09 | 4.10x |
| 2026-02-06 | 4.05x |
| 2026-02-05 | 3.88x |
| 2026-02-04 | 4.04x |
| 2026-02-03 | 4.12x |
| 2026-02-02 | 4.12x |
| 2026-01-30 | 4.20x |
| 2026-01-29 | 4.34x |
| 2026-01-28 | 4.34x |
| 2026-01-27 | 4.36x |
| 2026-01-26 | 4.24x |
| 2026-01-23 | 4.21x |
| 2026-01-22 | 4.11x |
| 2026-01-21 | 3.92x |
| 2026-01-20 | 3.79x |
| 2026-01-16 | 3.89x |
| 2026-01-15 | 3.93x |
| 2026-01-14 | 3.86x |
| 2026-01-13 | 3.82x |
| 2026-01-12 | 4.51x |
| 2026-01-09 | 8.11x |
| 2026-01-08 | 9.85x |
| 2026-01-07 | 8.69x |
| 2026-01-06 | 8.52x |
| 2026-01-05 | 9.58x |
| 2026-01-02 | 10.00x |
| 2025-12-31 | 10.15x |
| 2025-12-30 | 10.05x |
| 2025-12-29 | 10.10x |
| 2025-12-26 | 9.77x |
| 2025-12-24 | 9.92x |
| 2025-12-23 | 9.88x |
| 2025-12-22 | 10.04x |
| 2025-12-19 | 9.72x |
| 2025-12-18 | 9.75x |
| 2025-12-17 | 9.73x |
| 2025-12-16 | 9.91x |
| 2025-12-15 | 10.08x |
| 2025-12-12 | 10.11x |
| 2025-12-11 | 10.02x |
| 2025-12-10 | 9.57x |
| 2025-12-09 | 9.04x |
| 2025-12-08 | 8.76x |
| 2025-12-05 | 8.41x |
| 2025-12-04 | 8.35x |
| 2025-12-03 | 7.59x |
| 2025-12-02 | 7.44x |
| 2025-12-01 | 8.05x |
| 2025-11-28 | 8.77x |
| 2025-11-26 | 8.66x |
| 2025-11-25 | 8.52x |
| 2025-11-24 | 8.27x |
| 2025-11-21 | 8.11x |
| 2025-11-20 | 7.90x |
| 2025-11-19 | 8.14x |
| 2025-11-18 | 8.01x |
| 2025-11-17 | 7.84x |
| 2025-11-14 | 8.15x |
| 2025-11-13 | 7.98x |
| 2025-11-12 | 12.44x |
| 2025-11-11 | 12.53x |
| 2025-11-10 | 12.27x |
| 2025-11-07 | 11.79x |
| 2025-11-06 | 11.80x |
| 2025-11-05 | 10.73x |
| 2025-11-04 | 12.26x |
| 2025-11-03 | 13.81x |
| 2025-10-31 | 14.80x |
| 2025-10-30 | 14.01x |
| 2025-10-29 | 14.02x |
| 2025-10-28 | 15.16x |
| 2025-10-27 | 15.54x |
| 2025-10-24 | 14.45x |
| 2025-10-23 | 14.08x |
| 2025-10-22 | 14.59x |
| 2025-10-21 | 15.74x |
| 2025-10-20 | 15.99x |
| 2025-10-17 | 14.76x |
| 2025-10-16 | 15.20x |
| 2025-10-15 | 15.23x |
| 2025-10-14 | 14.57x |
| 2025-10-13 | 14.99x |
| 2025-10-10 | 14.29x |
| 2025-10-09 | 16.02x |
| 2025-10-08 | 15.80x |
| 2025-10-07 | 15.58x |
| 2025-10-06 | 13.94x |
| 2025-10-03 | 14.37x |
| 2025-10-02 | 14.44x |
| 2025-10-01 | 14.41x |
| 2025-09-30 | 14.29x |
| 2025-09-29 | 13.77x |
| 2025-09-26 | 13.70x |
| 2025-09-25 | 13.79x |
| 2025-09-24 | 14.22x |
| 2025-09-23 | 12.94x |
| 2025-09-22 | 12.27x |
| 2025-09-19 | 12.02x |
| 2025-09-18 | 12.04x |
| 2025-09-17 | 11.57x |
| 2025-09-16 | 11.49x |
| 2025-09-15 | 11.92x |
| 2025-09-12 | 12.09x |
| 2025-09-11 | 12.13x |
| 2025-09-10 | 11.76x |
| 2025-09-09 | 11.92x |
| 2025-09-08 | 12.15x |
| 2025-09-05 | 12.88x |
| 2025-09-04 | 12.77x |
| 2025-09-03 | 12.60x |
| 2025-09-02 | 12.31x |
| 2025-08-29 | 12.02x |
| 2025-08-28 | 12.33x |
| 2025-08-27 | 12.32x |
| 2025-08-26 | 12.61x |
| 2025-08-25 | 12.21x |
| 2025-08-22 | 12.31x |
| 2025-08-21 | 11.47x |
| 2025-08-20 | 11.74x |
| 2025-08-19 | 11.46x |
| 2025-08-18 | 11.46x |
| 2025-08-15 | 12.26x |
| 2025-08-14 | 11.70x |
| 2025-08-13 | 12.10x |
| 2025-08-12 | 11.52x |
